FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Consumer Drug Information Sheet

For current information on this drug, please see: http://www.fda.gov/cder/drug/infopage/abacavir/default.htm
Ziagen
Brand Name: Ziagen
Active Ingredient:   abacavir sulfate
Strength(s): 300mg oral tablets or 20mg/ml oral solution
Dosage Form(s):   Tablets and Oral solution
Company Name:    GlaxoSmithKline
Availability:         Prescription only
Date Approved by the FDA:   December 17, 1998

to top arrow Back to Top     back arrow Back to Abacavir

PDF document PDF requires the free Adobe Acrobat Reader

Date updated May 26, 2004, updated July 25, 2008

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research